FINHUB Insights

ZBH · Q1 FY25 · Jan 1 – Mar 31, 2025

Zimmer Biomet Q1 FY25: where the revenue came from and where it went

Zimmer Biomet Q1 FY25: revenue $1.9B (+1% year over year). Net profit $0.2B. Largest cohort Knees $0.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jan 1 – Mar 31, 2025
Reported
May 5, 2025 10-Q
Sankey diagram of Zimmer Biomet's income statement for Q1 FY25: revenue of $1.9 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$1.9B +1% year over year
Gross profit$1.4B 71% margin
Operating profit$0.3B 15% margin
Net profit$0.2B 10% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY25 (period ends Mar 31, 2025).
ItemValueShare of revenueYear over year
Revenue 1.9 100% +1%
Knees 0.8 42% +1%
Hips 0.5 26% +1%
SET 0.5 26% +4%
Technology and Data Bone Cement… 0.1 5% −5%
Cost of revenue−0.526%
Gross profit1.471% margin−2pp
SG&A−0.840%+1pp
Other−0.316%+0pp
Operating profit0.315% margin+1pp
Interest & other costs−0.1
Net profit0.210%+0pp
Filing on EDGAR More quarters of ZBH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters